G. M. Pasinetti and colleagues describe the role of insulin receptor (IR) signaling mechanisms in the onset and/or progression of AD dementia and the relevance of insulin-sensitizing therapeutic strategies to stimulate down-stream IR in nondiabetic AD patients. The gene discussed is INSR; the disease is dementia.